Skip to content
GLP-1 receptor agonists
-
Sciwind Biosciences gains Chinese approval for Ecnoglutide weight loss injection
The NMPA based its approval decision on Phase III clinical trial data published in The Lancet Diabetes & Endocrinology in June 2025.
-
WHO endorses GLP-1 receptor agonists for obesity treatment, urges expanded access
The guidance comes as more than one billion people worldwide currently live with obesity, a number projected to double by 2030 without decisive intervention.